Patent assignee · US · COMPANY

BeyondSpring Phamaceuticals, Inc.

18Patents
18Active
18Granted
52Portfolio score

Filing activity: Jul 12, 2012 → Nov 19, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10238650B2 Method of treating cancer associated with a RAS mutation Human Necessities 13 Active
US10076518B2 Method of treating a brain tumor Human Necessities 11 Active
US10155748B2 Plinabulin compositions Chemistry; Metallurgy 11 Active
US10550104B2 Plinabulin compositions Chemistry; Metallurgy 11 Active
US10357491B2 Method of treating a brain tumor Human Necessities 10 Active
US8618292B2 Analogs of dehydrophenylahistins and their therapeutic use Chemistry; Metallurgy 9 Active
US10668063B2 Method of treating cancer associated with a RAS mutation Human Necessities 9 Active
US11045467B2 Method of treating cancer associated with a RAS mutation Human Necessities 4 Active
US10912748B2 Compositions containing tucaresol or its analogs Chemistry; Metallurgy 4 Active
US11254657B2 Plinabulin compositions Chemistry; Metallurgy 2 Active
US11229642B2 Composition and method for reducing neutropenia Human Necessities 2 Active
US11918574B2 Method of treating cancer associated with a RAS mutation Human Necessities 1 Active
US11786523B2 Composition and method for reducing thrombocytopenia Human Necessities 1 Active
US11400086B2 Method of reducing chemotherapy-induced neutropenia Human Necessities 1 Active
US11857522B2 Compositions containing tucaresol or its analogs Chemistry; Metallurgy 1 Active
US12024501B2 Plinabulin compositions Chemistry; Metallurgy 1 Active
US11633393B2 Tubulin binding compounds and therapeutic use thereof Human Necessities 1 Active
US12377094B2 Therapeutic compositions and methods for treating checkpoint inhibitor-resistant tumors using plinabulin-based combination therapies Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.